Angiodynamics, Inc. (ANGO) Tops Q2 EPS by 1c; Guides Q3, Q4, FY12 EPS and Revs
Tweet
Share
E-mailGet Alerts ANGO Hot Sheet
Price: $15.55 -1.27%
Financial Fact:
Operating income: 3.57M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Operating income: 3.57M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Angiodynamics, Inc. (NASDAQ: ANGO) reported Q2 EPS of $0.13, $0.01 better than the analyst estimate of $0.12. Revenue for the quarter came in at $53.4 million versus the consensus estimate of $56.26 million.
Angiodynamics, Inc. sees Q3 2012 EPS of $0.09-$0.11, versus the consensus of $0.11. Angiodynamics, Inc. sees Q3 2012 revenue of $52-$54 million, versus the consensus of $54.65 million.
Angiodynamics, Inc. sees Q4 2012 EPS of $0.11-$0.13. Angiodynamics, Inc. sees Q4 2012 revenue of $53.5-$55.5 million.
Angiodynamics, Inc. sees FY2012 EPS of $0.41-$0.45, versus the consensus of $0.44. Angiodynamics, Inc. sees FY2012 revenue of $218-$222 million, versus the consensus of $219.9 million.
Angiodynamics, Inc. sees Q3 2012 EPS of $0.09-$0.11, versus the consensus of $0.11. Angiodynamics, Inc. sees Q3 2012 revenue of $52-$54 million, versus the consensus of $54.65 million.
Angiodynamics, Inc. sees Q4 2012 EPS of $0.11-$0.13. Angiodynamics, Inc. sees Q4 2012 revenue of $53.5-$55.5 million.
Angiodynamics, Inc. sees FY2012 EPS of $0.41-$0.45, versus the consensus of $0.44. Angiodynamics, Inc. sees FY2012 revenue of $218-$222 million, versus the consensus of $219.9 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance
- Candel Therapeutics, Inc. (CADL) Misses Q2 EPS by 29c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
